GUARDANT HEALTH, INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$902.57M
Revenue
$-398.79M
Net Income
-3.21
EPS (Diluted)
$-462.46M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-49.02%
Net Profit Margin
-44.18%
EBITDA
$-371.75M
Returns & Efficiency
Return on Assets (ROA)
-31.23%
Return on Equity (ROE)
-
Gross Profit
-
Operating Income
$-442.41M
Financial Health
Total Assets
$1.28B
Total Debt
-
Debt to Equity
-x
Current Ratio
3.50
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-3.21
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
3100 HANOVER STREET
PALO ALTO, CA 94304 |
| Phone | 855-698-8887 |
| Incorporated | DE, US |
| EIN | 454139254 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 124.81M |
| Stockholders' Equity | $-354.47M |
| Cash & Equivalents | $580.01M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-10-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-07-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-04-30
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-29
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-20
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-09
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
-
Operating Margin
-49.0%
Net Margin
-44.2%
ROE
-
ROA
-31.2%
Leverage & Liquidity
Debt to Equity
-
Current Ratio
3.50
Total Debt
-
Total Assets
$1.28B
Stockholders' Equity
$-354.47M
Income Statement (FY 2024)
Revenue
$902.57M
Gross Profit
-
Operating Income
$-442.41M
Net Income
$-398.79M
EPS (Diluted)
$-3.21
Cash Flow (FY 2024)
Free Cash Flow
$-462.46M
Cash & Equivalents
$580.01M
Revenue Growth
22.1%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...